Artículos relacionados a Phytomedicines of Europe: Chemistry and Biological...
Sinopsis
Book by None
"Sinopsis" puede pertenecer a otra edición de este libro.
Críticas
"This volume ... will be of widespread interest to anyone with an interest in current research in herbals and natural products. . . . [It] contains detailed discussions of analytical methods, mechanisms of action, and structure-activity relationships. In other words, [it] is a true medicinal chemistry text that is essential for understanding and accessing the literature of much of what is published elsewhere. . . . The usage and interest of phytomedicinals in the United States has taken on a more important perspective in the past few years. Yet, a concise, well-referenced publication on the medicinal chemistry of the discipline has been lacking. This text is concisely written, is clear, is full of data that would normally be hard to find, and takes a broad view of a major topic. After reading this book one has a fairly complete understanding of the state of the art of phytomedicines in Europe and, by extension, its future in the United States."--Journal of Medicinal Chemistry"Despite the title, Phytomedicines of Europe has a global audience. . . . The entire text is well-referenced with recent research. Even chemists who blanch at biology and biologists that cower at chemistry should easily comprehend the various principles advanced. The book also contains an excellent subject index. This text is a wake-up call to American researchers, pharmaceutical companies, physicians and consumers. Tyler mentions (p. 4) that of the 14 top-selling U.S. Phytomedicinals, 2/3 are popular mostly because of European research. . . . Despite our American love of a purified drug in a nice, easy-to-swallow pill, Phytomedicinal sales are booming in this country. Because of its importance to human health, the field of phytomedicinals in the U.S. should no longer carry the astigmatism of mysticism or quack medicine, but be included as a rational part of our research and health care."--Plant Science Bulletin"The proceeds of an August 1996 conference held in Orlando, Florida specifically to inform and inspire American scientists about the research on medicinal plants, which ahs continued in Germany and the rest of Europe but has been neglected in the US in favor of synthetic drugs. The herbs treated are not particularly European, The 21 papers address the status of phytopharmaceuticals within the European market, herbal drugs in the treatment of benign prostatic hyperplasia, plant polysaccharides and cancer, arnica flowers, echinacea, garlic, hawthorne, the influence of the flavonolignan silibinin of milk thistle on hepatocytes and kidney cells, St. John's wort, and lessons from research with mistletoe for phytotherapeutic immunomodulation as a treatment modality in oncology."--SciTech Book News "This volume ... will be of widespread interest to anyone with an interest in current research in herbals and natural products. . . . [It] contains detailed discussions of analytical methods, mechanisms of action, and structure-activity relationships. In other words, [it] is a true medicinal chemistry text that is essential for understanding and accessing the literature of much of what is published elsewhere. . . . The usage and interest of phytomedicinals in the United States has taken on a more important perspective in the past few years. Yet, a concise, well-referenced publication on the medicinal chemistry of the discipline has been lacking. This text is concisely written, is clear, is full of data that would normally be hard to find, and takes a broad view of a major topic. After reading this book one has a fairly complete understanding of the state of the art of phytomedicines in Europe and, by extension, its future in the United States."--Journal of Medicinal Chemistry"Despite the title, Phytomedicines of Europe has a global audience. . . . The entire text is well-referenced with recent research. Even chemists who blanch at biology and biologists that cower at chemistry should easily comprehend the various principles advanced. The book also contains an excellent subject index. This text is a wake-up call to American researchers, pharmaceutical companies, physicians and consumers. Tyler mentions (p. 4) that of the 14 top-selling U.S. Phytomedicinals, 2/3 are popular mostly because of European research. . . . Despite our American love of a purified drug in a nice, easy-to-swallow pill, Phytomedicinal sales are booming in this country. Because of its importance to human health, the field of phytomedicinals in the U.S. should no longer carry the astigmatism of mysticism or quack medicine, but be included as a rational part of our research and health care."--Plant Science Bulletin"The proceeds of an August 1996 conference held in Orlando, Florida specifically to inform and inspire American scientists about the research on medicinal plants, which ahs continued in Germany and the rest of Europe but has been neglected in the US in favor of synthetic drugs. The herbs treated are not particularly European, The 21 papers address the status of phytopharmaceuticals within the European market, herbal drugs in the treatment of benign prostatic hyperplasia, plant polysaccharides and cancer, arnica flowers, echinacea, garlic, hawthorne, the influence of the flavonolignan silibinin of milk thistle on hepatocytes and kidney cells, St. John's wort, and lessons from research with mistletoe for phytotherapeutic immunomodulation as a treatment modality in oncology."--SciTech Book News "This volume ... will be of widespread interest to anyone with an interest in current research in herbals and natural products. . . . [It] contains detailed discussions of analytical methods, mechanisms of action, and structure-activity relationships. In other words, [it] is a true medicinal chemistry text that is essential for understanding and accessing the literature of much of what is published elsewhere. . . . The usage and interest of phytomedicinals in the United States has taken on a more important perspective in the past few years. Yet, a concise, well-referenced publication on the medicinal chemistry of the discipline has been lacking. This text is concisely written, is clear, is full of data that would normally be hard to find, and takes a broad view of a major topic. After reading this book one has a fairly complete understanding of the state of the art of phytomedicines in Europe and, by extension, its future in the United States."--Journal of Medicinal Chemistry "Despite the title, Phytomedicines of Europe has a global audience. . . . The entire text is well-referenced with recent research. Even chemists who blanch at biology and biologists that cower at chemistry should easily comprehend the various principles advanced. The book also contains an excellent subject index. This text is a wake-up call to American researchers, pharmaceutical companies, physicians and consumers. Tyler mentions (p. 4) that of the 14 top-selling U.S. Phytomedicinals, 2/3 are popular mostly because of European research. . . . Despite our American love of a purified drug in a nice, easy-to-swallow pill, Phytomedicinal sales are booming in this country. Because of its importance to humanhealth, the field of phytomedicinals in the U.S. should no longer carry the astigmatism of mysticism or quack medicine, but be included as a rational part of our research and health care."--Plant Science Bulletin "The proceeds of an August 1996 conference held in Orlando, Florida specifically to inform and inspire American scientists about the research on medicinal plants, which ahs continued in Germany and the rest of Europe but has been neglected in the US in favor of synthetic drugs. The herbs treated are not particularly European, The 21 papers address the status of phytopharmaceuticals within the European market, herbal drugs in the treatment of benign prostatic hyperplasia, plant polysaccharides and cancer, arnica flowers, echinacea, garlic, hawthorne, the influence of the flavonolignan silibinin of milk thistle on hepatocytes and kidney cells, St. John's wort, and lessons from research with mistletoe for phytotherapeutic immunomodulation as a treatment modality in oncology."--SciTech Book News "This volume ... will be of widespread interest to anyone with an interest in current research in herbals and natural products. . . . [It] contains detailed discussions of analytical methods, mechanisms of action, and structure-activity relationships. In other words, [it] is a true medicinal chemistry text that is essential for understanding and accessing the literature of much of what is published elsewhere. . . . The usage and interest of phytomedicinals in the United States has taken on a more important perspective in the past few years. Yet, a concise, well-referenced publication on the medicinal chemistry of the discipline has been lacking. This text is concisely written, is clear, is full of data that would normally be hard to find, and takes a broad view of a major topic. After reading this book one has a fairly complete understanding of the state of the art of phytomedicines in Europe and, by extension, its future in the United States."--Journal of Medicinal Chemistry "Despite the title, Phytomedicines of Europe has a global audience. . . . The entire text is well-referenced with recent research. Even chemists who blanch at biology and biologists that cower at chemistry should easily comprehend the various principles advanced. The book also contains an excellent subject index. This text is a wake-up call to American researchers, pharmaceutical companies, physicians and consumers. Tyler mentions (p. 4) that of the 14 top-selling U.S. Phytomedicinals, 2/3 are popular mostly because of European research. . . . Despite our American love of a purified drug in a nice, easy-to-swallow pill, Phytomedicinal sales are boomingin this country. Because of its importance to human health, the field of phytomedicinals in the U.S. should no longer carry the astigmatism of mysticism or quack medicine, but be included as a rational part of our research and health care."--Plant Science Bulletin "The proceeds of an August 1996 conference held in Orlando, Florida specifically to inform and inspire American scientists about the research on medicinal plants, which ahs continued in Germany and the rest of Europe but has been neglected in the US in favor of synthetic drugs. The herbs treated are not particularly European, The 21 papers address the status of phytopharmaceuticals within the European market, herbal drugs in the treatment of benign prostatic hyperplasia, plant polysaccharides and cancer, arnica flowers, echinacea, garlic, hawthorne, the influence of the flavonolignan silibinin of milk thistle on hepatocytes and kidney cells, St. John's wort, and lessons from research with mistletoe for phytotherapeutic immunomodulation as a treatment modality in oncology."--SciTech Book News "This volume ... will be of widespread interest to anyone with an interest in current research in herbals and natural products. . . . [It] contains detailed discussions of analytical methods, mechanisms of action, and structure-activity relationships. In other words, [it] is a true medicinalchemistry text that is essential for understanding and accessing the literature of much of what is published elsewhere. . . . The usage and interest of phytomedicinals in the United States has taken on a more important perspective in the past few years. Yet, a concise, well-referenced publication onthe medicinal chemistry of the discipline has been lacking. This text is concisely written, is clear, is full of data that would normally be hard to find, and takes a broad view of a major topic. After reading this book one has a fairly complete understanding of the state of the art ofphytomedicines in Europe and, by extension, its future in the United States."--Journal of Medicinal Chemistry"Despite the title, Phytomedicines of Europe has a global audience. . . . The entire text is well-referenced with recent research. Even chemists who blanch at biology and biologists that cower at chemistry should easily comprehend the various principles advanced. The book also contains an excellentsubject index. This text is a wake-up call to American researchers, pharmaceutical companies, physicians and consumers. Tyler mentions (p. 4) that of the 14 top-selling U.S. Phytomedicinals, 2/3 are popular mostly because of European research. . . . Despite our American love of a purified drug in anice, easy-to-swallow pill, Phytomedicinal sales are booming in this country. Because of itsimportance to human health, the field of phytomedicinals in the U.S. should no longer carry the astigmatism of mysticism or quack medicine, but be included as a rational part of our research and healthcare."--Plant Science Bulletin"The proceeds of an August 1996 conference held in Orlando, Florida specifically to inform and inspire American scientists about the research on medicinal plants, which ahs continued in Germany and the rest of Europe but has been neglected in the US in favor of synthetic drugs. The herbs treated arenot particularly European, The 21 papers address the status of phytopharmaceuticals within the European market, herbal drugs in the treatment of benign prostatic hyperplasia, plant polysaccharides and cancer, arnica flowers, echinacea, garlic, hawthorne, the influence of the flavonolignan silibininof milk thistle on hepatocytes and kidney cells, St. John's wort, and lessons from research with mistletoe for phytotherapeutic immunomodulation as a treatment modality in oncology."--SciTech Book News
Reseña del editor
The first book in English on the medicinal plants of Europe, this volume contains up-to-date summaries by leading researchers on the pharmacological effects and active compounds for many widely used medicinal plants. It includes discussions of the German Commission E Monographs, of legal issues associated with selling herbs in the U.S., and of the status of European phytomedicines. The chapters are divided into reviews of general issues and detailed entries on specific plants.
"Sobre este título" puede pertenecer a otra edición de este libro.
- EditorialAmerican Chemical Society
- Año de publicación1998
- ISBN 10 0841235597
- ISBN 13 9780841235595
- EncuadernaciónTapa dura
- Número de páginas336
- EditorLawson Larry D., Bauer Rudolph
Los mejores resultados en AbeBooks
Imagen del vendedor
Phytomedicines of Europe: Chemistry and Biological Activity (ACS Symposium Series (No. 691))
Publicado por
American Chemical Society, 1998
ISBN 10: 0841235597
ISBN 13: 9780841235595
Antiguo o usado
Tapa dura
Librería: Bookstore Brengelman, Cincinnati, OH, Estados Unidos de America
Calificación del vendedor: 4 de 5 estrellas
Hardcover. Condición: As New. Hardcover without DJ. Nº de ref. del artículo: 0466230
Cantidad disponible: 1 disponibles
Imagen de archivo
Phytomedicines of Europe: Chemistry and Biological Activity (ACS Symposium Series, No. 691)
Publicado por
American Chemical Society, 1998
ISBN 10: 0841235597
ISBN 13: 9780841235595
Antiguo o usado
Tapa dura
Librería: SecondSale, Montgomery, IL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: Very Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc. Nº de ref. del artículo: 00037349502
Cantidad disponible: 1 disponibles
Imagen de archivo
Phytomedicines of Europe: Chemistry aLawson, Larry D.; Bauer, Rudolph
Publicado por
American Chemical Society, 1998
ISBN 10: 0841235597
ISBN 13: 9780841235595
Antiguo o usado
Tapa dura
Librería: Iridium_Books, DH, SE, España
Calificación del vendedor: 5 de 5 estrellas
Condición: Used - Good. Nº de ref. del artículo: 9780841235595
Cantidad disponible: 1 disponibles
Imagen de archivo
Phytomedicines of Europe Chemistry and Biological Activity (Hardback)
Publicado por
American Chemical Society, 1998
ISBN 10: 0841235597
ISBN 13: 9780841235595
Antiguo o usado
Tapa dura
Librería: Iridium_Books, DH, SE, España
Calificación del vendedor: 5 de 5 estrellas
Hardback. Condición: Muy Bueno / Very Good. Nº de ref. del artículo: 100000000672236
Cantidad disponible: 1 disponibles